HighPoint Advisor Group LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1616034
DOWNERS GROVE, IL
Position in REGN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$593,387
-$3,268 QoQ
Shares Held
768
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026HighPoint Advisor Group LLC holds $1,127,031 across 4 Biotechnology names. REGN ranks #1 (52.7% of the industry book) .
All Filings in REGN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $593,387 | 768 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $596,655 | 773 | Shares | Sole | 2026-05-14 | |
| 2025-09-30 | $764,124 | 1,359 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $830,025 | 1,581 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,029,989 | 1,624 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,280,057 | 1,797 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $2,200,245 | 2,093 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,173,530 | 2,068 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,788,306 | 1,858 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,588,826 | 1,809 | Shares | Sole | 2024-03-26 | |
| 2022-06-30 | $471,721 | 798 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $606,390 | 1,002 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $215,596 | 386 | Shares | Sole | 2021-07-29 | |
| 2020-12-31 | $290,349 | 601 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $224,471 | 401 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $241,352 | 387 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $179,690 | 368 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||